lorazepam has been researched along with 3,4-methylenedioxyamphetamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Böning, J; Wodarz, N | 1 |
Coulter, C; Garnier, M; Moore, C | 1 |
2 other study(ies) available for lorazepam and 3,4-methylenedioxyamphetamine
Article | Year |
---|---|
["Ecstasy"-induced psychotic depersonalization syndrome].
Topics: 3,4-Methylenedioxyamphetamine; Adult; Combined Modality Therapy; Depersonalization; Designer Drugs; Dose-Response Relationship, Drug; Female; Fluvoxamine; Humans; Lorazepam; N-Methyl-3,4-methylenedioxyamphetamine; Psychoses, Substance-Induced; Suicide; Suicide Prevention | 1993 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |